ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

703 hedge funds and large institutions have $22.6B invested in Alexion Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 261 increasing their positions, 262 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
703
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
18
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$275M
Puts
$315M
Net Calls
Net Calls Change

Top Buyers

1 +$324M
2 +$150M
3 +$94.5M
4
AL
AJO LP
Pennsylvania
+$91.5M
5
Nomura Holdings
Nomura Holdings
Japan
+$67.7M

Top Sellers

1 -$495M
2 -$367M
3 -$107M
4
HM
HealthCor Management
New York
-$74.8M
5
DnB Asset Management
DnB Asset Management
Norway
-$74.1M
Name Holding Trade Value Shares
Change
Change in
Stake
601
$42K
602
$40K
603
$39K
604
$39K
605
$35K
606
$35K
607
$35K
608
$34K
609
$33K
610
$32K
611
$30K
612
$30K
613
$29K
614
$27.7K
615
$27K
616
$26K
617
$26K
618
$23K
619
$23K
620
$23K
621
$23K
622
$21K
623
$21K
624
$20K
625
$20K